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Aims and method We conducted a secondary analysis of data from the National
Audit of Psychosis to identify factors associated with use of community treatment
orders (CTOs) and assess the quality of care that people on CTOs receive.
Results Between 1.1 and 20.2% of patients in each trust were being treated on a
CTO. Male gender, younger age, greater use of in-patient services, coexisting
substance misuse and problems with cognition predicted use of CTOs. Patients on
CTOs were more likely to be screened for physical health, have a current care plan,
be given contact details for crisis support, and be offered cognitive–behavioural
therapy.
Clinical implications CTOs appear to be used as a framework for delivering higher-
quality care to people with more complex needs. High levels of variation in the use of
CTOs indicate a need for better evidence about the effects of this approach to patient
care.
Declaration of interest None.
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Community treatment orders (CTOs) were introduced in
England and Wales in 2008, in an attempt to reduce the
use of in-patient services for patients with poor adherence
to their treatment.1–3 They require individuals with mental
disorders who have been detained in hospital to adhere to
treatment and supervision in the community.
Non-compliance with CTOs may lead to revocation, where
the patient is involuntarily admitted back into hospital for
further treatment. The use of similar legislation to enforce
community treatment also exists in other countries, includ-
ing the USA, Australia and New Zealand.4,5
Although CTOs have been recommended as a method
for improving adherence and patient safety, patients treated
under CTOs feel more coerced.6 The use of CTOs has been
much higher than was initially anticipated,7,8 and has
increased considerably since they were first introduced.8,9
Concerns have been raised about greater use of compulsion
amongst people from ethnic minority communities.10–12
Data submitted to NHS Digital in 2016 indicated that
Black or Black British patients were almost nine times
more likely to be treated on a CTO than White British
patients.13 A systematic review of data from 38 studies of
clinical practice in the UK, which compared the use of
in-patient mental health services by different ethnic groups,
found that Black patients were over four times more likely to
be admitted to hospital on a compulsory basis than White
patients.10 However, other studies have reported that asso-
ciations between use of compulsory treatment and ethnicity
may be reduced or eliminated when other sociodemographic
and clinical factors are taken into account.14,15 To date, the
influence of clinical and sociodemographic factors on the
association between ethnicity and use of CTOs has not
been examined.
There is considerable variation in the experiences of
people treated under CTOs.6 Surveys of both patients and
carers indicate that many believe their main aim is to try
to force people to take regular mediation.6,16 It has been
argued that use of CTOs can improve a person’s mental
health and quality of life, but negative findings of rando-
mised trials17,18 and limited information about the quality
of care that people actually receive have led to calls for fur-
ther research in this area.11,19
The National Clinical Audit of Psychosis is a 10 year
programme of work commissioned by the Healthcare
Quality Improvement Partnership as part of the National
Clinical Audit and Patient Outcomes Programme in
England and Wales, which aims to improve the quality of
care that people with psychosis receive.20 In the light of con-
cerns about increasing use of CTOs, patient representatives
from the Steering Committee that oversees this programme
ORIGINAL PAPER
1
of work requested that data on use of CTOs be included in
the third round of the audit. By collecting data on whether
people in the audit were being treated using a CTO, we
aimed to identify patient characteristics that predict use of
CTOs in England and Wales and to explore the quality of
care received by people who were treated under a CTO com-
pared with those who were not.
Method
This study was based on a secondary analysis of data from
the third round of the National Clinical Audit of
Psychosis.21 Data for the audit were obtained from clinical
records of patients between September and November
2017. The study population were patients aged 16 or over
who had received care from a provider of National Health
Service (NHS) mental health services for at least 12 months
on a census date (1 July 2017). To take part in the audit a
patient had to have a current ICD-10 diagnosis of psychotic
disorder secondary to alcohol or substance abuse, schizo-
phrenia, persistent delusional disorder, schizoaffective dis-
order or other non-organic or unspecified psychotic
disorders made before the age of 60 and 12 months or longer
before the census date.22
All providers of mental health services in England and
Wales were helped to generate a random sample of eligible
patients. The sample size for each trust was between 100
and 300 patients, depending on the size of the trust.22 For
each selected patient, staff working in the trust extracted
data from electronic and other patient records to complete
a 49-item online data collection form. This form included
questions on demographic factors (including age, gender
and ethnicity), clinical factors (including whether the patient
had received in-patient treatment during the previous 12
months and whether the patient was currently in remission),
data on the physical and mental healthcare that the patient
had received, and scores from the Health of the Nation
Outcome Scales (HoNOS) completed during the previous 12
months.22 HoNOS is a clinician-rated outcome measure
which assesses patients’ difficulties in a variety of mental
health domains during the 2 weeks leading up to the point
of rating. Scores for each domain range from 0 (absent) to 4
(severe), with higher scores indicating greater impairment.23
Finally, we collected data from a single item that asked
whether the patient was currently being treated on a CTO.
Prior to the start of the audit, the National Research
Ethics Service and the Ethics and Confidentiality
Committee of the National Information Governance Board
advised that formal ethical approval was not required for
this quality improvement initiative. Approval for the second-
ary analysis of the data in this study was obtained from the
Healthcare Quality Improvement Partnership prior to the
start of data analysis.
Data management and analysis
We excluded data from people who were in-patients at the
point when data were collected, because it was unclear
whether or not such patients had been treated using a
CTO prior to their admission. For this analysis, we extracted
data from the audit on demographic, clinical and service fac-
tors, together with information about whether the patient
was currently being treated using a CTO, and evaluated
the association between CTO treatment and demographic,
clinical and service provision factors. Among all patients
being treated in the community, we calculated the propor-
tion of people currently being treated on a CTO, together
with 95% confidence intervals.
We used χ2 tests and Mann–Whitney U-tests to compare
the demographic and clinical characteristics of patients trea-
ted under CTOs with those of patients who were not. We then
used univariate ordinal logistic regression to compare
HoNOS ratings between patients who were treated under
CTOs and those who were not. Demographic and clinical vari-
ables identified as differing significantly between patients
treated under CTOs and others (P < 0.05) were then entered
into a multivariate logistic regression in order to determine
which variables were independently associated with a greater
likelihood of treatment under a CTO. The multivariate logis-
tic regression used multilevel modelling with a random effect
for NHS trust in order to adjust for differences between NHS
trusts in frequency of CTO usage.
Differences in service provision between patients who
were treated under a CTO and thosewhowere not were exam-
ined using multilevel logistic regression, adjusting for poten-
tial demographic and clinical confounders (age, sex, ethnicity,
in-patient psychiatric hospital admission in the past 12
months), and including a random effect for patients’ NHS
trust in order to adjust for differences between NHS trusts
in service provision. We compared 15 aspects of the quality
of physical and mental healthcare that people received:
whether the patient was prescribed a single antipsychotic
drug; whether the current daily dose of antipsychotic medica-
tion was within the upper limits recommended in the British
National Formulary;24 whether the patient had ever been
offered cognitive–behavioural therapy for psychosis (CBTp);
whether patients in contact with their families had been
offered family intervention; whether the patient had been
screened for smoking, harmful alcohol use, and substance
misuse; whether interventions were offered for smoking ces-
sation, or alcohol or substance use to those requiring them;
whether the patient had a current care plan; whether there
Table 1 Number and proportion of people with psychosis
on a CTO in England and Wales
Area N
On
CTO
Not on
CTO
% on a
CTO 95% CI
Total 8760 529 8231 6.04 (5.55–6.53)
London 1514 92 1422 6.08 (4.88–7.28)
North
East
2140 135 2005 6.31 (5.28–7.33)
North
West
1244 95 1149 7.64 (6.16–9.11)
South
East
1973 113 1860 5.73 (4.71–6.75)
South
West
1492 63 1429 4.22 (3.20–5.24)
Wales 397 31 366 7.81 (5.17–10.45)
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was documented evidence that the patient had been given
information about how to contact healthcare services if in cri-
sis; whether the patient had been offered support to obtain
employment; and whether or not there was documented evi-
dence that any identified carer had been offered an assess-
ment of their needs.
All statistical analysis was carried out using SPSS ver-
sion 21 or Stata SE version 14.2.25,26
Results
All 62 trusts and health boards in England and Wales took
part in the audit. Data were collected from 9449 patients,
of whom 8760 patients were being treated in the community
and were therefore eligible for this study. Table 1 lists the
frequency of use of CTOs at a national and regional level.
Across England and Wales, 6.04% (n = 529) of patients
were being treated on a CTO at the time of the audit. The
proportion of people being treated on a CTO was highest
in Wales and lowest in the South West of England. There
was also considerable variation in use of CTOs among
patients treated across the 62 trusts and health boards, ran-
ging from 1.06 to 20.22%.
Predictors of use of CTOs
Demographic and clinical characteristics of patients who
were and were not treated under a CTO are presented in
Table 2 Comparison of demographic and clinical characteristics of patients treated and not treated on a CTO
Variable
Treated on CTO Not treated on CTO
P-value (Z or χ2)Mean/n % Mean/n %
Mean age in years (s.d.) 44.05 11.51 46.84 11.35 <0.001* (5.450)
Gender 0.013* (8.733)
Male 367 69.38 5334 64.80
Female 161 30.43 2895 35.17
Other/undefined 1 0.19 2 0.02
Ethnicity 0.001* (19.910)
White 399 75.43 6454 78.41
Black or Black British 71 13.42 717 8.71
Asian or British Asian 26 4.91 640 7.78
Mixed 17 3.21 192 2.33
Other ethnic groups 16 3.02 228 2.77
Diagnosis <0.001* (19.914)
F10–19 Substance-induced 17 3.21 230 2.79
F20 Schizophrenia 368 69.57 5946 72.24
F25 Schizoaffective disorder 118 22.31 1341 16.29
F22, F24, F28, F29 Other 26 4.91 714 8.68
Time since diagnosis 0.654 (0.201)
Less than 3 years 103 19.47 1538 18.69
3 years or longer 426 80.53 6693 81.31
Current mental health <0.001* (63.464)
Full remission 81 15.31 2088 25.37
Partial remission – minimal symptoms 255 48.20 4258 51.73
Partial remission – substantial symptoms 165 31.19 1529 18.58
Not in remission 28 5.29 356 4.33
Alcohol consumption 0.852 (0.035)
Harmful use 67 29.26 875 28.68
No harmful use 162 70.74 2176 71.32
Substance misuse <0.001* (96.656)
Yes 159 33.40 1229 17.46
No 317 66.60 5810 82.54
Use of in-patient services <0.001* (391.357)
Admitted in past 12 months 224 42.3 975 11.9
No admission 305 57.7 7526 88.2
* P < 0.05.
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Table 3 HONOS scores of 5960 patients according to whether treated on a CTO
HONOS item Score
On a CTO
N = 347
n (%)
Not on a CTO
N = 5613
n (%) Odds ratio 95% CI P-value
Overactive, aggressive, disruptive or agitated behaviour 0 130 (37) 3062 (55) 1.98 1.63–2.41 <0.001
1 99 (29) 1382 (25)
2 80 (23) 810 (14)
3 25 (7) 301 (5)
4 13 (4) 58 (1)
Non-accidental self-injury 0 298 (86) 4820 (86) 1.03 0.76–1.41 0.834
1 23 (7) 474 (8)
2 15 (4) 201 (4)
3 8 (2) 91 (1.5)
4 2 (1) 24 (0.5)
Problem drinking or drug-taking 0 192 (55) 3897 (69) 1.85 1.50–2.28 <0.001
1 44 (13) 627 (11)
2 54 (16) 523 (9)
3 40 (11) 412 (7)
4 16 (5) 135 (2)
Cognitive problems 0 148 (43) 2934 (52) 1.52 1.25–1.86 <0.001
1 91 (26) 1432(26)
2 76 (22) 904 (16)
3 29 (8) 287 (5)
4 3 (1) 49 (1)
Physical illness or disability problems 0 164 (47) 2448 (44) 0.88 0.72–1.07 0.192
1 72 (21) 1227 (22)
2 70 (20) 1168 (21)
3 35 (10) 620 (11)
4 6 (2) 134 (2)
Problems associated with hallucinations and delusions 0 54 (16) 1453 (26) 1.92 1.60–2.34 <0.001
1 68 (20) 1156 (21)
2 97 (28) 1782 (32)
3 90 (26) 975 (17)
4 36 (10) 231 (4)
Problems with depressed mood 0 133 (39) 2235 (40) 1.01 0.83–1.23 0.923
1 112 (32) 1731 (31)
2 79 (23) 1251 (22)
3 17 (5) 355 (6)
4 3 (1) 34 (1)
Other mental and behavioural problems 0 97 (28) 1700 (30) 1.07 0.88–1.30 0.496
1 71 (21) 1063 (19)
2 98 (29) 1655 (30)
3 60 (17) 1005 (18)
4 16 (5) 167 (3)
Problems with relationships 0 67 (19) 1835 (33) 2.08 1.71–2.53 <0.001
1 78 (23) 1452 (26)
2 101 (29) 1458 (26)
3 83 (24) 739 (13)
4 16 (5) 113 (2)
Continued
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Table 2, and HoNOS scores of the two groups are presented
in Table 3. Among the 6853 White British patients, 399
(5.82%) were currently being treated on a CTO; among the
788 patients whose ethnicity was recorded as Black or
Black British, 71 (9.02%) were currently being treated on a
CTO. Scores on all but four HoNOS items were higher
among those treated on a CTO compared to those who
were not. Differences in the use of CTOs across trusts
explained 5.0% of the overall variance in use of CTOs
(95% C.I. 2.70–8.77). In the multivariate multilevel model
using a random effect for NHS trust, the variables signifi-
cantly independently predicting a greater likelihood of
CTO use were: younger age, male gender, psychiatric hos-
pital admission in the past 12 months, current substance
misuse, and greater levels of cognitive problems on the
HoNOS (Table 4).
Quality of care delivered to patients on CTOs
Data on the quality of care provided to patients who were
and were not being treated on a CTO are presented in
Table 5. After adjusting for age, sex, ethnicity and history
of in-patient psychiatric hospital admission in the past 12
months, patients treated on a CTO were more likely to be
screened for smoking and substance misuse, have a current
care plan, have documented evidence of being given contact
details to be used in a crisis, and be offered CBTp.
Discussion
The results of this study suggest that, in England and Wales,
age, gender, coexisting substance misuse and problems with
cognition predict whether people are treated on a CTO.
Previous studies have reported higher rates of substance
misuse among people who are treated in the community
on a compulsory basis.27 People who have substance misuse
problems in addition to psychosis are more likely to relapse
and more likely to be admitted to hospital.28,29 Data from
this study suggest that clinicians use CTOs to provide a
framework for trying to mitigate against these risks.
By contrast, previous studies of compulsory community
treatment have not examined the influence of cognitive
impairment on the use of CTOs. Problems with cognition
are defined in the HoNOS as ‘problems of memory, orienta-
tion and understanding associated with any disorder: learn-
ing disability, dementia, schizophrenia’.23 We did not collect
data on whether people in the audit had other coexisting
mental health conditions. However, whether the higher
levels of cognitive problems rated on the HoNOS among
those treated on CTOs resulted from coexisting intellectual
impairment or were directly associated with their psych-
osis,30 it seems that clinicians are more likely to use CTOs
when patients with psychosis also have difficulties with mak-
ing decisions and organising their lives. Surveys of clinicians
in both the UK and New Zealand indicate that the most
important role of CTOs is ensuring that patients maintain
their contact with mental health services.31,32 Clinical
teams may judge that the power of recall helps ensure that
people with psychosis who have impaired cognition maintain
their contact with services.
We did not find evidence that ethnicity was an inde-
pendent predictor of the use of CTOs. While Black and
Black British patients were 55% more likely to be treated
on a CTO than White British patients, differences in the
adjusted odds of being treated on a CTOs among ethnic
groups were not statistically significant. Nor did we find evi-
dence that other aspects of mental state, including suicidal
behaviour or problems associated with hallucinations and
delusions, predicted use of CTOs.
Table 3 Continued
HONOS item
Score On a CTO
N = 347
n (%)
Not on a CTO
N = 5613
n (%) Odds ratio 95% CI P-value
Problems with activities of daily living 0 86 (25) 1845 (33) 1.43 1.18–1.73 <0.001
1 80 (23) 1366 (24)
2 108 (31) 1, 513(27)
3 60 (18) 762 (14)
4 10 (3) 120 (2)
Problems with living conditions 0 188 (55) 3633 (65) 1.58 1.28–1.95 <0.001
1 72 (21) 973 (17)
2 44 (13) 622 (11)
3 29 (8) 269 (5)
4 12 (3) 91 (2)
Problems with occupation and activities 0 99 (29) 2063 (37) 1.47 1.21–1.79 <0.001
1 74 (22) 1246 (22)
2 97 (28) 1426 (25)
3 60 (17) 706 (13)
4 15 (4) 153 (3)
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Study strengths and limitations
The main strength of this study is that we were able to ana-
lyse data on patients from all trusts in England and Wales,
which means that we can be confident that these findings
are generalisable across the country. Another strength is
that there was little missing data. The items with the largest
amount of missing data were scores on the HoNOS, but even
these scores were available for 70% of study patients. The
inclusion of HoNOS data was important as it enabled us to
examine whether demographic factors truly influence the
use of CTOs once the potentially confounding effects of clin-
ical variables have been taken into account.
The main limitation of the study is the reliance on data
which were retrospectively extracted from patient records.
This means that if interventions were delivered but not
documented, these would not have been included in our ana-
lysis. Various steps were taken to maximise the reliability of
data gathered in the audit, including piloting the data collec-
tion tool during an earlier round of the audit and providing
comprehensive guideline notes for those tasked with extract-
ing and entering data on the audit’s online data management
platform. Although questions have been raised about the
reliability of HoNOS,33 it remains the only outcome measure
in widespread use in the UK and therefore provides a valu-
able source of routine data on the health and social function-
ing of people who use secondary care mental health
services.34,35 We were able to analyse data from a large sam-
ple of over 8000 patients. However, the relatively small
numbers of patients on a CTO meant that we had limited
power to examine differences in use of CTOs among some
groups of patients. Although we are only able to report on
the use of CTOs among people with schizophrenia and
related psychoses, most people treated using a CTO have
psychosis. It is important that future research examine fac-
tors that influence the use of CTOs among all those who may
be treated under them, including people with intellectual
disability.
Implications of study findings
The results of this study provide some assurance about the
quality of care that people treated using CTOs in England
and Wales receive. Rather than simply being a means to
encourage adherence to medication or attend follow-up
Table 4 Multivariate logistic regression for sociodemographic and clinical predictors of CTO use
Independent variablea Odds ratio 95% CI P-value
Age 0.98 0.96–1.00 0.049
Gender: Male 1 – –
Female 0.48 0.28–0.80 0.005
Ethnicity: White 1 – –
Black or Black British 1.35 0.77–2.36 0.297
Asian or British Asian 0.76 0.28–2.04 0.587
Mixed 0.99 0.36–2.75 0.983
Other ethnic groups 1.82 0.52–6.35 0.347
Diagnosis: Other psychoses 1 – –
Schizophrenia 1.06 0.68–1.65 0.790
Mental health: Partial/ no remission 1 –
Full remission 0.68 0.38–1.22 0.203
Harmful alcohol consumption: No 1 – –
Yes 0.74 0.47–1.16 0.186
Substance misuse: No 1 – –
Yes 1.98 1.28–3.05 0.002
Psychiatric hospital admission: No 1 – –
Yes 4.57 3.07–6.79 <0.001
HONOS Overactive, aggressive, behaviour 1.05 0.85–1.28 0.661
HONOS Problem drinking or drug-taking 0.93 0.78–1.10 0.388
HONOS Cognitive problems 1.28 1.04–1.57 0.021
HONOS Problems with hallucinations and delusions 1.08 0.90–1.30 0.397
HONOS Problems with relationships 1.21 1.02–2.08 0.080
HONOS Problems with activities of daily living 0.94 0.75–1.18 0.597
HONOS Problems with living conditions 1.07 0.88–1.30 0.484
HONOS Problems with occupation and activities 0.93 0.77–1.14 0.509
a. Adjusted for NHS trust.
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Table 5 Descriptive statistics and logistic regression comparing quality of care received by patients on a CTO and those who
were not
Aspect of carea
On CTO
N = 529
Not on CTO
N = 8231
Odds ratio 95% CI P-valuen % n %
Was screening for smoking carried out? 1.61 1.14–2.30 0.008
Yes 490 92.63 7114 86.43
No 37 7.37 1117 13.57
Was screening for alcohol misuse carried out? 1.35 0.95–1.93 0.096
Yes 490 92.63 7261 88.22
No 39 7.37 970 11.78
Was screening for substance misuse carried out? 1.49 1.03–2.15 0.032
Yes 493 93.19 7203 87.51
No 36 6.81 1028 12.49
Was intervention for smoking offered if needed?b 1.30 0.94–1.80 0.108
Offered 272 81.19 3060 78.7
Not offered 63 18.81 830 21.34
Was intervention for alcohol offered if needed?b 1.00 0.41–2.44 0.999
Offeredc 60 89.55 775 88.57
Not offered 7 10.45 100 11.43
Was intervention for substance misuse offered?b 1.05 0.64–1.74 0.834
Offeredc 133 83.65 1022 83.16
Not offered 26 16.35 207 16.84
Polypharmacy being used 0.84 0.65–1.08 0.163
Yes 82 15.59 1440 18.22
No 444 84.41 6464 81.78
Total antipsychotic drug dose above BNF maxima 0.79 0.54–1.16 0.228
Yes 32 6.08 573 7.25
No 494 93.92 7331 92.75
Evidence of patient involvement in deciding antipsychotic medication 1.05 0.86–1.28 0.648
Yes 351 66.73 5181 65.55
No 175 33.27 2723 34.45
Current care plan 2.97 1.71–5.18 <0.001
Yes 514 97.16 7597 92.30
No 15 2.84 634 7.70
Crisis contact details provided 1.62 1.15–2.26 0.005
Yes 484 91.49 7183 87.27
No 45 8.51 1048 12.73
Offered CBTp? 1.27 1.03–1.56 0.026
Yes 168 31.76 2144 26.05
No 361 68.24 6087 73.95
Offered family interventiond 1.24 0.86–1.78 0.248
Yes 66 39.76 796 32.77
No 100 60.24 1633 67.23
Offered work support programmee 0.53 0.16–1.83 0.317
Yes 12 63.16 242 76.34
No 7 36.84 75 23.66
Continued
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appointments, people on CTOs in this study were more
likely to be referred for psychological therapy and to have
documented evidence of care plans and assessment of
their physical health. Although many patients treated
under CTOs believe that they are used to enforce use of
medication,6 the results of this study indicate that people
on CTOs may be receiving better quality of care overall.
Nonetheless, it is important to note that even among people
on CTOs, standards of care, especially in relation to psycho-
logical treatments and physical health assessment, fall below
recommended standards.36
Arguably the most important finding in this study is the
high degree of variation in use of CTOs across different
trusts and in different parts of the country. CTOs represent
a significant limitation on the rights of patients, and the high
level of variation is therefore of concern.12 There are a num-
ber of possible explanations for this variation. These include
random variation resulting from study sampling, differences
in the populations served by different trusts and differences
in the organisation and delivery of local services. Trevithick
and colleagues noted that trusts serving large urban centres
have higher rates of CTO use.8 Studies have also shown that
there are higher rates of CTO use in trusts that provide spe-
cialist services for people with intellectual disability.8,31
Another reason for differences in levels of use of CTOs
in different parts of the country could be continuing uncer-
tainty about the clinical effectiveness of this approach to
helping people with psychosis. While the results of the
OCTET trial and other randomised trials of compulsory
community treatment suggest that CTOs do not reduce
use of in-patient services or lead to improved mental health
or quality of life,17,18 questions have been raised about
whether the results of these trials can be generalised to rou-
tine clinical settings37 and many psychiatrists remain con-
vinced of their benefit. It seems likely, given this degree of
uncertainty, that the extent to which different teams use
CTOs is influenced by the opinions and experiences of clin-
icians who are responsible for delivering patient care.
Conclusions
The findings of this study suggest that, in addition to marked
variation at the trust level, male gender, younger age,
coexisting substance misuse and problems with cognition
influence the use of CTOs in England and Wales. Patients
treated on CTOs appear to be receiving higher quality of
care than those who are treated on a voluntary basis.
These results highlight the need for further research into
the costs and benefits of treating patients using CTOs so
that unwarranted variation in their use can be minimised.
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